Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
May 3 15:27 ET
Ultragenyx Pharmaceutical | 10-Q: Quarterly report
May 3 15:13 ET
Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
May 2 16:05 ET
Ultragenyx Pharmaceutical | DEFA14A: Others
Apr 26 16:40 ET
Ultragenyx Pharmaceutical | ARS: Annual Report to Security Holders
Apr 26 16:40 ET
Ultragenyx Pharmaceutical | DEF 14A: Definitive information statements
Apr 26 16:39 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
Apr 19 16:40 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Apr 18 18:07 ET
Ultragenyx Pharmaceutical | 8-K: Current report
Apr 15 08:08 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard
Mar 12 13:43 ET
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 11 18:43 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Mar 11 12:57 ET
Ultragenyx Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 7 16:16 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Horn Howard
Mar 5 20:24 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Parschauer Karah Herdman
Mar 5 20:24 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Kassberg Thomas Richard
Mar 5 20:24 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Pinion John Richard
Mar 5 20:20 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huang Dennis Karl
Mar 5 20:19 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Huizenga Theodore Alan
Mar 5 20:14 ET
Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Crombez Eric
Mar 5 20:14 ET
No Data
No Data